期刊文献+

TIP30和骨桥蛋白在喉鳞状细胞癌中的表达及意义 被引量:1

Expression and clinical significances of TIP30 and OPN in laryngeal squamous cell carcinoma
原文传递
导出
摘要 目的探讨喉鳞状细胞癌组织中TIP30与骨桥蛋白(OPN)的表达及意义。方法应用免疫组织化学SP法检测60例喉鳞状细胞癌(A组)及癌旁组织(B组)TIP30与OPN的表达,分析TIP30表达与喉鳞状细胞癌临床病理特征的关系。结果 A组TIP30表达率低于B组(45.0%vs.78.3%)(P<0.05)。A组OPN表达率高于B组(73.3%vs.25.0%)(P<0.05)。TIP30蛋白的表达与临床分期、病理组织学分级和颈部淋巴结转移有关(P<0.05)。在喉鳞状细胞癌组织中,TIP30与OPN在蛋白水平的表达呈负相关(P<0.05)。结论 TIP30可能在喉鳞状细胞癌发生、发展和转移中起重要作用,可作为肿瘤标志物用于喉鳞状细胞癌临床诊断和预后判断。 Objective To investigate the expression and clinical significances of TIP30and osteopontin(OPN)in laryngeal squamous cell carcinoma(LSCC).Methods The expressions of TIP30and OPN were detected by immunohistochemical SP method in 60LSCC specimens(group A)and tumor-adjacent normal tissues(group B).The relationship between the expressions of TIP30and OPN and clinicopathological features of LSCC was analyzed.Results The positive expression rate of TIP30was lower in group A than that of group B(45.0% vs.78.3%)(P〈0.05).The positive expression rate of OPN was higher in group A than that in group B(73.3% vs.25.0%)(P〈0.05).The expression level of TIP30 was significantly correlated with tumor stage,grade and lymph node matastasis(P〈0.05),but not correlated with age,gender and tumor primary site(P〉0.05).The expression level of TIP30was negatively correlated to that of OPN in group A(P〈0.05).Conclusion TIP30may play a important role in the development and metastasis of LSCC,and could be taken as a marker for clinical diagnosis and prediction of prognosis in the patients with LSCC.
出处 《江苏医药》 CAS 北大核心 2014年第13期1511-1513,共3页 Jiangsu Medical Journal
基金 南通市科技计划指导性项目(S11918)
关键词 TIP30 骨桥蛋白 喉鳞状细胞癌 Tip30 Osteopontin Laryngeal squamous cell carcinoma
  • 相关文献

参考文献11

  • 1Chu EA,Kim YJ.Laryngeal cancer:diagnosis and preoperative work-up[J].Otolaryngol Clin North AM,2008,41(4):673-695.
  • 2Zhao J,Ni H,Ma Y,et al.TIP30/CC3expression in breast carcinoma:relation to metastasis,clinicopathologic parameters,and P53expression[J].Human Pathol,2007,38(2):293-298.
  • 3Ha PK,Califano JA 3rd.The molecular biology of laryngeal cancer[J].Otolaryngol Clin North Am,2002,35(5):993-1012.
  • 4Shtivelman E.A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma[J].Oncogene,1997,14(18):2167-2173.
  • 5Mehlen P,Puisieux A.Metastasis:aquestion of life or death[J].Nature Rev Cancer,2006,6(6):449-458.
  • 6Zhang X,Tsukamoto T,Mizoshita T,et al.Expression of ostepopontin and CDX2:indication of TIP phenotypes prognosis advanced gastric cancer[J].Oncol Rep,2009,21(3):609-613.
  • 7Briese J,Cheng S,Ezzat S,et al.Osteopontin(OPN)expression in thyroid carcinoma[J].Anticancer Res,2010,30(5):1681-1688.
  • 8Chen RX,Xia YH,Cui JF,et al.Osteopontin,a single marker for predicting the prognosis of patients with tumor-nodemetastasis stage I hepatocellular carcinoma after surgical resection[J].J Gastroenterol Hepatol,2010,25(8):1435-1442.
  • 9Eto M,Kodama S,Nomi N,et al.Clinical significance of elevated osteopontin levels in head and neck cancer patient[J].Auris Nasus Larynx,2007,34(3):343-346.
  • 10Zhao J,Lu B,Xu H,et al.Thirty-kilodahon Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma[J].Hepatology,2008,48(10):265-275.

同被引文献13

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部